The indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Georgia Research Foundation, Inc. (UGA Research Foundation), a non-profit organization. The single-award IDC has a ceiling value of $146.3 million over 7 years and focuses on developing and employing animal and animal replacement models of infectious diseases to support NIAID's pandemic preparedness...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3 million Indefinite Delivery Contract (IDC) to The Research Foundation For The State University Of New York to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. This IDC contains four task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded this $146.3 million single award Indefinite Delivery Contract to the University of Louisville to provide preclinical models of infectious diseases over a 7-year ordering period ending in 2031. The contract supports NIAID's mission to facilitate research on understanding, treating, and preventing infectious diseases by enabling the development and refinement of small animal, non-human primate, and non-traditional animal...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, has awarded a single-award Indefinite Delivery Contract (IDC) valued at $146.3 million to the University of Cincinnati. The contract, titled "Pre-Clinical Models of Infectious Diseases - Task Area A," has an ordering period through July 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop, refine, and employ...
This indefinite delivery contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. federal government, aims to provide the capability and capacity to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. The single-award contract, with a 7-year ordering period and a ceiling value of $146.3 million, was awarded to Sigmovir Biosystems, Inc., a...
The Indefinite Delivery Contract (IDC) 75N93024D00028 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Tennessee, a non-profit educational institution. The $146.3M contract has an ordering period ending in July 2031 and covers the development and use of animal and animal replacement models to evaluate candidate countermeasures (e.g., therapeutics, vaccines,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, awarded a $146.3 million Indefinite Delivery Contract (IDC) to Institute For Clinical Pharmacodynamics, Inc., a for-profit organization, to provide pre-clinical models of infectious diseases under Task Area C. The period of performance is from July 15, 2024 to July 14, 2031. The contract is a follow-on to a previous Preclinical Models of Infectious Diseases...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Emory University, a private research university. The contract has a ceiling value of $146,300,000 and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with the capability to develop, refine, and employ small animal models, non-human primate models, animal...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $146.3 million single-award Indefinite Delivery Contract (IDC) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) in July 2024. This 7-year contract focuses on developing and employing animal and animal replacement models to support NIAID's pandemic preparedness efforts. The contract covers four main task areas: small animal models, non-human primate models, animal replacement and non-traditional animal models, and generation of specialized reagents. This IDC positions UGA Research Foundation to play a crucial role in evaluating therapeutics, vaccines, and diagnostics for a range of priority infectious diseases, including emerging viral threats and antimicrobial resistant infections. The original solicitation was a Small Business Sources Sought notice published in October 2022, seeking qualified small businesses to provide these research and development services. The contract is not set-aside and allows for the use of subcontractors and other organizations to supplement UGA Research Foundation's capabilities as needed.